vs
Side-by-side financial comparison of Anika Therapeutics, Inc. (ANIK) and FRANKLIN STREET PROPERTIES CORP (FSP). Click either name above to swap in a different company.
Anika Therapeutics, Inc. is the larger business by last-quarter revenue ($29.6M vs $26.0M, roughly 1.1× FRANKLIN STREET PROPERTIES CORP). On growth, Anika Therapeutics, Inc. posted the faster year-over-year revenue change (13.2% vs -8.2%). Over the past eight quarters, Anika Therapeutics, Inc.'s revenue compounded faster (-1.8% CAGR vs -8.7%).
Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.
ANIK vs FSP — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $29.6M | $26.0M |
| Net Profit | — | $-7.3M |
| Gross Margin | 64.2% | 59.4% |
| Operating Margin | 17.3% | -27.9% |
| Net Margin | — | -28.1% |
| Revenue YoY | 13.2% | -8.2% |
| Net Profit YoY | — | 14.1% |
| EPS (diluted) | $0.27 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $29.6M | — | ||
| Q4 25 | $30.6M | $26.0M | ||
| Q3 25 | $27.8M | $27.3M | ||
| Q2 25 | $28.2M | $26.7M | ||
| Q1 25 | $26.2M | $27.1M | ||
| Q4 24 | $30.6M | $28.4M | ||
| Q3 24 | $29.6M | $29.7M | ||
| Q2 24 | $30.7M | $30.8M |
| Q1 26 | — | — | ||
| Q4 25 | $292.0K | $-7.3M | ||
| Q3 25 | $-2.3M | $-8.3M | ||
| Q2 25 | $-4.0M | $-7.9M | ||
| Q1 25 | $-4.9M | $-21.4M | ||
| Q4 24 | $-21.9M | $-8.5M | ||
| Q3 24 | $-29.9M | $-15.6M | ||
| Q2 24 | $-88.0K | $-21.0M |
| Q1 26 | 64.2% | — | ||
| Q4 25 | 62.6% | 59.4% | ||
| Q3 25 | 56.0% | 60.9% | ||
| Q2 25 | 50.9% | 59.9% | ||
| Q1 25 | 56.1% | 62.8% | ||
| Q4 24 | 56.0% | 59.7% | ||
| Q3 24 | 65.7% | 61.0% | ||
| Q2 24 | 66.7% | 64.2% |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 2.1% | -27.9% | ||
| Q3 25 | -11.6% | -30.5% | ||
| Q2 25 | -14.8% | -29.2% | ||
| Q1 25 | -16.4% | -78.9% | ||
| Q4 24 | -2.3% | -29.9% | ||
| Q3 24 | -0.3% | -52.4% | ||
| Q2 24 | -5.9% | -68.0% |
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | -28.1% | ||
| Q3 25 | -8.4% | -30.5% | ||
| Q2 25 | -14.1% | -29.5% | ||
| Q1 25 | -18.6% | -79.1% | ||
| Q4 24 | -71.4% | -30.0% | ||
| Q3 24 | -101.2% | -52.6% | ||
| Q2 24 | -0.3% | -68.2% |
| Q1 26 | $0.27 | — | ||
| Q4 25 | $0.02 | $-0.06 | ||
| Q3 25 | $-0.16 | $-0.08 | ||
| Q2 25 | $-0.28 | $-0.08 | ||
| Q1 25 | $-0.34 | $-0.21 | ||
| Q4 24 | $-1.49 | $-0.09 | ||
| Q3 24 | $-2.03 | $-0.15 | ||
| Q2 24 | $0.00 | $-0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.0M | $30.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $133.9M | $607.0M |
| Total Assets | $179.4M | $892.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $41.0M | — | ||
| Q4 25 | $81.2M | $30.6M | ||
| Q3 25 | $80.2M | $31.4M | ||
| Q2 25 | $77.1M | $29.4M | ||
| Q1 25 | $75.4M | $30.2M | ||
| Q4 24 | $79.2M | $41.1M | ||
| Q3 24 | $90.7M | $40.9M | ||
| Q2 24 | $96.6M | $30.2M |
| Q1 26 | $133.9M | — | ||
| Q4 25 | $143.5M | $607.0M | ||
| Q3 25 | $146.8M | $615.3M | ||
| Q2 25 | $147.7M | $624.7M | ||
| Q1 25 | $148.4M | $633.4M | ||
| Q4 24 | $154.0M | $655.9M | ||
| Q3 24 | $179.9M | $665.4M | ||
| Q2 24 | $210.3M | $682.1M |
| Q1 26 | $179.4M | — | ||
| Q4 25 | $190.3M | $892.9M | ||
| Q3 25 | $189.4M | $901.0M | ||
| Q2 25 | $187.7M | $903.2M | ||
| Q1 25 | $190.6M | $916.4M | ||
| Q4 24 | $202.7M | $946.9M | ||
| Q3 24 | $231.4M | $981.5M | ||
| Q2 24 | $262.7M | $1.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $3.8M |
| Free Cash FlowOCF − Capex | — | $-12.7M |
| FCF MarginFCF / Revenue | — | -48.6% |
| Capex IntensityCapex / Revenue | — | 63.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-25.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.6M | $3.8M | ||
| Q3 25 | $6.9M | $8.3M | ||
| Q2 25 | $-189.0K | $-2.9M | ||
| Q1 25 | $-130.0K | $-5.5M | ||
| Q4 24 | $1.6M | $9.0M | ||
| Q3 24 | $5.0M | $14.5M | ||
| Q2 24 | $-1.1M | $-648.0K |
| Q1 26 | — | — | ||
| Q4 25 | $4.0M | $-12.7M | ||
| Q3 25 | $5.0M | $3.0M | ||
| Q2 25 | $-1.7M | $-5.7M | ||
| Q1 25 | $-3.0M | $-9.9M | ||
| Q4 24 | $275.0K | $-16.2M | ||
| Q3 24 | $3.8M | $8.6M | ||
| Q2 24 | $-4.5M | $-5.1M |
| Q1 26 | — | — | ||
| Q4 25 | 13.0% | -48.6% | ||
| Q3 25 | 17.9% | 11.0% | ||
| Q2 25 | -5.9% | -21.5% | ||
| Q1 25 | -11.3% | -36.7% | ||
| Q4 24 | 0.9% | -57.2% | ||
| Q3 24 | 12.9% | 29.1% | ||
| Q2 24 | -14.6% | -16.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 63.0% | ||
| Q3 25 | 6.8% | 19.4% | ||
| Q2 25 | 5.2% | 10.7% | ||
| Q1 25 | 10.8% | 16.4% | ||
| Q4 24 | 4.3% | 88.9% | ||
| Q3 24 | 4.1% | 19.6% | ||
| Q2 24 | 11.1% | 14.6% |
| Q1 26 | — | — | ||
| Q4 25 | 15.88× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANIK
| OEM Channel | $17.0M | 57% |
| Commercial Channel | $12.6M | 43% |
FSP
Segment breakdown not available.
